← Evidence map

ReviewGene therapy2012

Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade.

J Reinkober et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 22336718